Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRani Therapeutics Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
Rani Therapeutics Holdings, Inc. Earnings Date And Information
Rani Therapeutics Holdings, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.24 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Rani Therapeutics Holdings, Inc. has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -1.31. Rani Therapeutics Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Rani Therapeutics Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.22 | -$0.24 | -0.02 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.29 | -$0.26 | 0.03 | $0 | $0 |
| 05/06/2024 | Q1 2024 | -$0.29 | $0 | |||
| 03/20/2024 | Q4 2023 | -$0.31 | -$0.27 | 0.04 | $2.75 M | |
| 11/08/2023 | Q3 2023 | -$0.47 | -$0.36 | 0.11 | $0 | |
| 08/11/2023 | Q2 2023 | -$0.37 | $0 | |||
| 05/10/2023 | Q1 2023 | -$0.47 | -$0.33 | 0.14 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.26 | -$0.70 | -0.44 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.33 | -$0.66 | -0.33 | $130,000 | $0 |
| 08/10/2022 | Q2 2022 | -$0.28 | -$0.66 | -0.38 | $130,000 | $0 |
| 05/11/2022 | Q1 2022 | -$1.00 | -$0.65 | 0.35 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.68 | $-2,717,000 | |||
| 11/15/2021 | Q3 2021 | -$0.16 | $630,000 | $0 | ||
| 09/13/2021 | Q2 2021 | -$0.00 | $490,000 | $1.96 M | ||
| 03/30/2021 | Q1 2021 | -$0.30 | $756,000 | |||
| 12/30/2020 | Q4 2020 | -$0.89 | $210,000 | |||
| 09/29/2020 | Q3 2020 | -$0.15 | $108,000 | |||
| 06/29/2020 | Q2 2020 | -$0.14 | $60,000 | |||
| 03/30/2020 | Q1 2020 | -$0.29 | $83,000 |
Rani Therapeutics Holdings, Inc. Earnings: FAQ's
When is Rani Therapeutics Holdings, Inc.'s earnings date?
Rani Therapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
How can I listen to Rani Therapeutics Holdings, Inc.'s earnings conference
call?
The conference call for Rani Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.
How can I read Rani Therapeutics Holdings, Inc.'s conference call transcript?
The conference call transcript for Rani Therapeutics Holdings, Inc.'s latest earnings report can be read online.
How much profit does Rani Therapeutics Holdings, Inc. generate each year?
Rani Therapeutics Holdings, Inc. (:RANI) has a recorded net income of $0. Rani Therapeutics Holdings, Inc. has generated $-1.33 earnings per share over the last four quarters.
What is Rani Therapeutics Holdings, Inc.'s price-to-earnings ratio?
Rani Therapeutics Holdings, Inc. (:RANI) has a price-to-earnings ratio of -1.31 and price/earnings-to-growth ratio is -0.13.